Progression of asthma: Small steps and a long way to go

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 3, 2004, Pages 206-207

  Pedersen, Søren ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; PLACEBO; SALMETEROL;

AGE; AIRWAY; ASTHMA; DISEASE COURSE; EDITORIAL; FORCED EXPIRATORY VOLUME; GENETIC HETEROGENEITY; HEIGHT; HUMAN; LUNG FUNCTION; PREDICTION; PRIORITY JOURNAL; PUBERTY;

ADOLESCENT; ADULT; AGE FACTORS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; DISEASE PROGRESSION; HUMANS; INFLAMMATION; RESPIRATORY FUNCTION TESTS;

EID: 3242750438     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (14)

1. Covar RA, Spahn JD, Murphy JR, Szefler SJ. Progression of asthma measured by lung function in the Childhood Asthma Management Program. Am J Respir Crit Care Med 2004;170:234-241.
2. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-1063.
3. The Childhood Asthma Management Program Research Group. Design, rationale, and methods. Control Clin Trials 1999;20:91-120.
4. Zeiger RS, Dawson C, Weiss S. Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP). J Allergy Clin Immunol 1999;103:376-387.
5. Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, Ullman A, Lamm CJ, O'Byrne PM. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003;361:1071-1076.
6. Verberne AA, Frost C, Roorda RJ, van der Laag H, Kerrebijn K. One year treatment with salmeterol, compared with beclomethasone in children with asthma. Am J Respir Crit Care Med 1997;156:688-695.
7. Merkus PJ, van Pelt W, van Houwelingen JC, van Essen Zandvliet LEM, Duiverman EC, Kerrebijn KF, Quanjer PH. Inhaled corticosteroids and growth of lung function in asthmatic children. Eur J Respir Dis 2004; (In press)
8. Phelan PD, Robertson CF, Olinsky A. The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol 2002;109:189-194.
9. Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, Sears MR. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. Am J Respir Crit Care Med 2002;165:1480-1488.
10. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339:1194-1200.
11. Martinez F, Wright AL, Taussig L, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-138.
12. Gerritsen J, Koeter GH, Postma DS, Schouten JP, Knol K. Prognosis of asthma from childhood to adulthood. Am Rev Respir Dis 1989;140: 1325-1330.
13. DeGroodt EG, van Pelt W, Borsboom GJ, Quanjer PH, van Zomeren BC. Growth of lung and thorax dimensions during the pubertal growth spurt. Eur Respir J 1988;1:102-108.
14. DeGroodt EG, Quanjer PH, Wise ME, van Zomeren BC. Changing relationships between stature and lung volumes during puberty. Respir Physiol 1986;65:139-153.